Table 1 Experimental validation of the calculated optimized formulation.
Central composite design (CCD) optimization | Albumin concentration (mg) X1 | Glutaraldehyde (%) X2 | Particle size (nm) Y1 | PDI Y2 | Zeta potential (mV) Y3 |
|---|---|---|---|---|---|
Theoretical | 129.16 | 4.73 | 138.69 | 0.21 | 17.7 |
Practical/experimental | 130.00 | 5.00 | 167.57 | 0.25 | 16.2 |